n the latest ‘get tough’ move by the FDA against wayward compounding pharmacies, the agency has filed a lawsuit seeking a permanent injunction against a New Jersey pharmacy called Med Prep Consulting for a host of violations associated with distributing contaminated medications.
The move comes three months after Med Prep recalled all of its nearly 100 products after a Connecticut hospital noticed "visible particulate contaminants" that turned out to be mold in 50 millimeter bags of an intravenous solution (back story). New Jersey officials then took legal action to revoke its permit and license (see this).
continue reading here